ScholarWorks@SUNGKYUNKWAN UNIVERSITY: Search

Current filters:

Current filters:

Results 21-30 of 245 (Search time: 0.511 seconds).

SCIESCOPUS

SKYSCRAPER-09: A phase II, randomised, double-blinded study of atezolizumab (Atezo) plus tiragolumab (Tira) and atezo plus placebo as first-line (1L) therapy for recurrent/metastatic (R/M) PD-L1+squamous cell carcinoma of the head and neck (SCCHN)

Cohen, E[Cohen, E.]; Fayette, J[Fayette, J.]; Harrington, KJ[Harrington, K. J.]; Johnson, ML[Johnson, M. L.]; Kao, HF[Kao, H-F.]; Lee, SH[Lee, S-H.]; Licitra, LF[Licitra, L. F.]; Ngamphaiboon, N[Ngamphaiboon, N.]; Psyrri, A[Psyrri, A.]; Wong, DJ[Wong, D. J.], et al.

ArticleIssue Date2021CitationANNALS OF ONCOLOGY, v.32, pp.S814 - S815PublisherELSEVIER

SCIESCOPUS

Larotrectinib treatment of advanced TRK fusion thyroid cancer

Cabanillas, ME[Cabanillas, M. E.]; Drilon, A[Drilon, A.]; Farago, AF[Farago, A. F.]; Brose, MS[Brose, M. S.]; McDermott, R[McDermott, R.]; Sohal, D[Sohal, D.]; Oh, DY[Oh, D-Y.]; Almubarak, M[Almubarak, M.]; Bauman, J[Bauman, J.]; Chu, E[Chu, E.], et al.

ArticleIssue Date2020CitationANNALS OF ONCOLOGY, v.31, pp.S1086 - S1086PublisherELSEVIER

SCIESCOPUS

Patient-reported outcomes (PROs) from patients (Pts) with NTRK fusion-positive (NTRK-fp) solid tumours receiving entrectinib in the global phase II STARTRK-2 study

Conley, AP[Conley, A. P.]; Demetri, GD[Demetri, G. D.]; Doebele, RC[Doebele, R. C.]; Drilon, A[Drilon, A.]; Paz-Ares, L[Paz-Ares, L.]; Cassier, P[Cassier, P.]; Siena, S[Siena, S.]; Ahn, MJ[Ahn, M-J.]; Buchschacher, GL[Buchschacher, G. L., Jr.]; Seto, T[Seto, T.], et al.

ArticleIssue Date2020CitationANNALS OF ONCOLOGY, v.31, pp.S471 - S472PublisherELSEVIER

SCIESCOPUS

Results of KEYNOTE-122: A phase III study of pembrolizumab (pembro) monotherapy vs chemotherapy (chemo) for platinum-pretreated, recurrent or metastatic (R/M) nasopharyngeal carcinoma (NPC)

Chan, AT[Chan, A. T.]; Lee, VHF[Lee, V. H. F.]; Hong, RL[Hong, R-L.]; Ahn, MJ[Ahn, M-J.]; Chong, WQ[Chong, W. Q.]; Kim, SB[Kim, S-B.]; Fuang, HG[Fuang, H. Gwo]; Caguioa, PB[Caguioa, P. B.]; Ngamphaiboon, N[Ngamphaiboon, N.]; Ho, C[Ho, C.], et al.

ArticleIssue Date2021CitationANNALS OF ONCOLOGY, v.32, pp.S786 - S786PublisherELSEVIER

SCIESCOPUS

Efficacy and safety with selpercatinib by last prior systemic therapy received in patients (Pts) with RET fusion plus non-small cell lung cancer (NSCLC)

Gautschi, O[Gautschi, O.]; Drilon, A[Drilon, A.]; Tan, DSW[Tan, D. S. W.]; Oxnard, GR[Oxnard, G. R.]; McCoach, C[McCoach, C.]; Goto, K[Goto, K.]; Park, K[Park, K.]; Casal, GA[Alonso Casal, G.]; de Braud, F[de Braud, F.]; French, P[French, P.], et al.

ArticleIssue Date2020CitationANNALS OF ONCOLOGY, v.31, pp.S835 - S835PublisherELSEVIER

SCIESCOPUS

Efficacy and safety of ceritinib 450 mg-fed vs 750 mg-fasted in Asian patients (pts) with ALK plus non-small cell lung cancer (NSCLC) in the ASCEND-8 trial

Cho, BCC[Cho, B. C. Chul]; Kim, DW[Kim, D-W.]; Batra, U[Batra, U.]; Park, K[Park, K.]; Kim, SW[Kim, S-W.]; Yang, CT[Yang, C. T.]; Jye, VP[Jye, V. Pie]; Sriuranpong, V[Sriuranpong, V.]; Babu, KG[Babu, K. G.]; Amin, K[Amin, K.], et al.

ArticleIssue Date2020CitationANNALS OF ONCOLOGY, v.31, pp.S864 - S865PublisherELSEVIER

SCIESCOPUS

4-year survival in randomised phase II (POPLAR) and phase III (OAK) studies of atezolizumab (atezo) vs docetaxel (doc) in pre-treated NSCLC

Mazieres, J[Mazieres, J.]; Rittmeyer, A[Rittmeyer, A.]; Gadgeel, SM[Gadgeel, S. M.]; Hida, T[Hida, T.]; Gandara, D[Gandara, D.]; Cortinovis, D[Cortinovis, D.]; Barlesi, F[Barlesi, F.]; Yu, W[Yu, W.]; Matheny, C[Matheny, C.]; Ballinger, M[Ballinger, M.], et al.

ArticleIssue Date2020CitationANNALS OF ONCOLOGY, v.31, pp.S821 - S822PublisherELSEVIER

SCIESCOPUS

Risk and management of intracranial progression on amivantamab in epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins)-mutated non-small cell lung cancer (NSCLC)open access

Trigo, J[Trigo, J.]; Cho, BC[Cho, B. C.]; Park, K[Park, K.]; Girard, N[Girard, N.]; Viteri, S[Viteri, S.]; Garrido, P[Garrido, P.]; Krebs, MG[Krebs, M. G.]; Thayu, M[Thayu, M.]; Knoblauch, RE[Knoblauch, R. E.]; Xie, J[Xie, J.], et al.

ArticleIssue Date2022CitationANNALS OF ONCOLOGY, v.33, pp.S38 - S39PublisherELSEVIER

SCIESCOPUS

Comparison of clinical characteristics and prognosis of incidentally detected and screening detected lung cancers open access

Zo, S[Zo, S.]; Shin, SH[Shin, S. H.]; Jeong, BH[Jeong, B-H.]; Lee, K[Lee, K.]; Kim, H[Kim, H.]; Kwon, OJ[Kwon, O. J.]; Um, SW[Um, S-W.]

ArticleIssue Date2022CitationANNALS OF ONCOLOGY, v.33, pp.S79 - S79PublisherELSEVIER

SCIESCOPUS

Clinical utility of plasma cell-free DNA EGFR mutation analysis in treatment-naive stage IV non-small cell lung cancer patients open access

Kim, BG[Kim, B-G.]

ArticleIssue Date2022CitationANNALS OF ONCOLOGY, v.33, pp.S59 - S59PublisherELSEVIER

previous 1 2 3 4 5 6 next 25

Discover

STATISTICS: Total View :5,504,177; Today View :813

RSS_1.0 RSS_2.0 ATOM_1.0

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREAsamsunglib@skku.edu

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Discover

Author

Subject

Date Issued

Type

Language

Journal Index

BROWSE